328.20CHF-0.06%Mkt Cap: 261.12B CHFP/E: 20.45Last update: 2026-05-13
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas o…
Industry Peers
Drug Manufacturers - Generalloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)20.45
P/E (Forward)15.16
PEG1.44
P/B7.81
P/S4.17
EV/EBITDA11.88
EV/Revenue4.51
EPS (TTM)16.03
EPS (Forward)21.88
Cash Flow & Leverage
FCF Yield4.22%
FCF Margin17.41%
Operating CF18.85B CHF
CapEx (TTM)5.78B CHF
Net Debt/EBITDA0.74
Net Debt17.71B CHF
Technical
SMA 50329.28 (-0.3%)
SMA 200317.52 (+3.4%)
Beta0.33
S&P 52W Chg24.23%
Avg Vol (30d)28.66K
Avg Vol (10d)24.74K
Technical Indicators
RSI (14)49.6
MACD-1.2213
MACD Signal-1.6312
MACD Hist.+0.4098
BB Upper334.06 CHF
BB Middle327.87 CHF
BB Lower321.68 CHF
BB Width3.78%
ATR (14)6.440 CHF
Vol Ratio (20d)0.91x
52W Range
256.4057% of range383.00
52W High383.00 CHF
52W Low256.40 CHF
Profitability
Gross Margin73.73%
EBITDA Margin37.95%
Profit Margin20.33%
Oper. Margin29.99%
ROE38.10%
ROA12.79%
Revenue Growth-0.40%
Earnings Growth171.30%
Balance Sheet
Debt/Equity0.98
Current Ratio1.38
Quick Ratio1.05
Book Value/Sh42.48 CHF
Cash/Share19.46 CHF
Dividends
Fwd Div Rate9.800 CHF
Trail. Div Rate9.800 CHF
Div. Yield2.95%
5Y Avg Yield3.04%
Payout Ratio60.47%
Ex-Div DateMar 12, 2026
Pay DateMar 31, 2025
Splits
Last Split100:1
Split DateMay 4, 2011
Ownership
Shares Out.106.69M
Float652.94M
Insiders72.57%
Institutions10.30%
Analyst Consensus
Rating—
Target (Mean)367.00 CHF
Target Range340.00 CHF – 396.00 CHF
# Analysts3
Company
Market Cap261.12B CHF
Enterprise Value285.77B CHF
Revenue (TTM)63.36B CHF
Gross Profit46.71B CHF
Net Income (TTM)12.88B CHF
Revenue/Share79.59 CHF
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
Last Price328.20 CHF
CountryCH
SectorHealthcare
IndustryDrug Manufacturers - General
ISINCH0012032048